# Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

> **NCT02218320** · — · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 20 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Dolutegravir
- **PROCEDURE:** Colonoscopy with biopsy

## Key facts

- **NCT ID:** NCT02218320
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218320, "Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02218320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*